Kaja Giżewska-Kacprzak

Dr. Kaja Giżewska-Kacprzak


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2024 in Children
Verified
Journal Article
Open access
PDF file
KGKaja Giżewska-Kacprzak
Kaja Giżewska-Kacprzak
MŚMaximilian Śliwiński
Maximilian Śliwiński
KNKarol Nicieja
Karol Nicieja
LBLidia Babiak-Choroszczak
Lidia Babiak-Choroszczak
IWIreneusz Walaszek
Ireneusz Walaszek
Macrodactyly is a rare congenital limb difference manifesting as an overgrowth of one or more fingers or toes. The pathological process affects all tissues of the ray in the hand or foot. The enlargement can significantly alter the limb’s appearance and impair its function. The role of a pediatrician is to distinguish isolated macrodactyly from syndromic conditions (including PIK3CA-Related Overgrowth Spectrum) or mimicking conditions to enable early interdisciplinary consultation and treatment planning. The psychological stigma associated with this often disfiguring condition necessitates support for patients and their family. We present a practical guide for physicians who might be the first to raise suspicion of macrodactyly and initiate further diagnostics to achieve adequate treatment and support for children and caregivers.

30 July 2024 in Genes
Verified
Journal Article
Open access
PDF file
ALAlicja Leśniak
Alicja Leśniak
MGMarta Glińska
Marta Glińska
MPMichal Patalan
Michal Patalan
IOIwona Ostrowska
Iwona Ostrowska
MŚMonika Grażyna Świrska-Sobolewska
Monika Grażyna Świrska-Sobolewska
Maria GiżewskaMaria Giżewska
Maria Giżewska
Spinal muscular atrophy with respiratory distress type 1 (SMARD1; OMIM #604320, ORPHA:98920) is a rare autosomal recessive congenital motor neuron disease. It is caused by variants in the IGHMBP2 gene. Clinically, it presents with respiratory failure due to diaphragmatic paralysis, progressive muscle weakness starting in the distal parts of the limbs, dysphagia, and damage to sensory and autonomic nerves. Unlike spinal muscular atrophy (SMA), SMARD1 has a distinct genetic etiology and is not detected in the population newborn screening programs. Most children with SMARD1 do not survive beyond the first year of life due to progressive respiratory failure. Artificial ventilation can prolong survival, but no specific treatment is available. Therapy focuses on mechanical ventilation and improving the patient’s quality of life. Research into gene therapy is ongoing. We report three female patients with SMARD1, including twins from a triplet pregnancy. In twin sisters (patient no. 1 and patient no. 2), two heterozygous variants in the IGHMBP2 gene were identified: c.595G>C/p.Ala199Pro and c.1615_1623del/p.Ser539_Tyr541del. In patient no. 3, a variant c.1478C>T/p.Thr493Ile and a variant c.439C>T/p.Arg147* in the IGHMBP2 gene were detected. Our findings underscore the variability of clinical presentations, even among patients sharing the same pathogenic variants in the IGHMBP2 gene, and emphasize the importance of early genetic diagnosis in patients presenting with respiratory failure, with or without associated diaphragmatic muscle paralysis.

29 April 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MTMarlena Telenga
Marlena Telenga
ARAnna Rozensztrauch
Anna Rozensztrauch
KGKaja Giżewska-Kacprzak
Kaja Giżewska-Kacprzak
RŚRobert Śmigiel
Robert Śmigiel
Background: Pitt–Hopkins syndrome (PTHS) is a rare genetic disorder affecting psychomotor, social, and intellectual development, caused by a mutation in the TCF4 gene. The study aims to gather the phenotype and genotype data of PTHS patients from Poland and to assess the quality of life (QoL) and the impact of the disorders on the family. Methods: Eight families with PTHS participated in the study. To obtain data, the following standardized questionnaires were used: Questionnaire on Clinical Problems (QCP), the PedsQL™ Family Impact Module, and the QL-Disability Questionnaire. Additionally, a retrospective analysis of clinical examination, genetic consult, medical history, and genotype of each individual was performed. Results: All of the examined children exhibited a mutation in the TCF4 gene and typical features of PTHS. The most prevalent clinical symptoms in the study group included typical PTHS appearance, intellectual disability (n = 5; as the rest of the patients were too young to be assessed), abnormal speech development (n = 8), reduced pain response (n = 7), constipation (n = 7), drooling (n = 7), cold extremities (n = 7), and disturbances in sensory integration processes (n = 7). The QL-Disability Questionnaire revealed a total QoL score of 67.7/100 for children with PTHS, while the QoL for their families in the PedsQL Family Impact Module was 53.82/100. The highest-rated domain was cognitive functioning (Median (Me) = 67.50; Standard Deviation (SD) = 21.95), while the lowest was daily activities (Me = 25.00; SD = 29.86). Conclusions: The study allowed the collection of data on the phenotype and genotype of children with PTHS living in Poland. Overall, our study showed that the QoL of children with PTHS is impaired.

23 April 2024 in Cureus
Verified
Journal Article
Open access
PDF file
KGKaja Giżewska-Kacprzak
Kaja Giżewska-Kacprzak
KNKarol Nicieja
Karol Nicieja
BGBartosz Gajek
Bartosz Gajek
LBLidia Babiak-Choroszczak
Lidia Babiak-Choroszczak
Magnet ingestion can lead to serious health issues, including inflammation, gastrointestinal tract perforation, and even life-threatening complications. Despite legislative actions and numerous reports on the dangers of magnet ingestion in children, it remains a significant public health concern. Physicians must remain vigilant in cases of acute abdomen with ambiguous symptoms or unclear history in young patients. Prompt diagnosis and surgical intervention in case of multiple magnet swallowing are crucial to prevent complications. We present two cases of successful removal of ingested magnetic spheres through laparoscopic appendectomy in adolescents. This study aimed to highlight the technical aspects of the procedure to share the benefits of minimally invasive surgery (MIS) in the management of magnetic foreign bodies (FBs) located in the appendix or cecum.

Verified
Journal Article
Open access
PDF file
IWIreneusz Walaszek
Ireneusz Walaszek
DSDaria Schneider-Matyka
Daria Schneider-Matyka
MBMateusz Bosiacki
Mateusz Bosiacki
SGSzymon Grochans
Szymon Grochans
KGKaja Giżewska-Kacprzak
Kaja Giżewska-Kacprzak
Kamila RachubińskaKamila Rachubińska
Kamila Rachubińska
Upper limb disorders, including carpal tunnel syndrome (CTS), are a common cause of pain, functional limitations, and reduced quality of life. Increasing attention has been directed toward the role of inflammatory and angiogenic mediators in the pathophysiology of CTS and their potential relationship with patient-reported functional outcomes. The aim of this study was to evaluate selected cytokines as potential markers of upper limb disability assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. This cross-sectional study included 55 patients with idiopathic CTS referred for surgical treatment. Functional impairment was assessed using the DASH questionnaire, and concentrations of selected inflammatory and angiogenic mediators—IL-4, IL-6, MCP-1, TNF-α, VEGF, and fraktalkine—were measured in synovial tissue samples; these markers were selected based on their established roles in inflammation, angiogenesis, and nociceptive modulation relevant to CTS pathophysiology. VEGF was identified as a significant predictor of DASH category (p = 0.032), with higher concentrations associated with a lower likelihood of severe upper limb dysfunction. In contrast, higher TNF-α levels were associated with an increased risk of severe disability (p = 0.031). Other cytokines did not demonstrate significant associations with functional impairment. These findings suggest that selected inflammatory and angiogenic mediators were associated with the severity of functional disability in CTS and warrant investigation in prospective longitudinal studies to clarify their potential role alongside patient-reported outcome measures.

Verified
Journal Article
Open access
PDF file
IWIreneusz Walaszek
Ireneusz Walaszek
KGKaja Giżewska-Kacprzak
Kaja Giżewska-Kacprzak
SGSzymon Grochans
Szymon Grochans
Kamila RachubińskaKamila Rachubińska
Kamila Rachubińska
EGElzbieta Grochans
Elzbieta Grochans
Anna Maria CybulskaAnna Maria Cybulska
Anna Maria Cybulska
Objectives: This systematic review and meta-analysis aimed to assess whether serum inflammatory markers are associated with Carpal Tunnel Syndrome (CTS), moving beyond the traditional mechanical explanation. Methods: Seven observational studies involving a total of 609 adult participants (CTS patients and matched healthy controls) were included. Studies were selected through comprehensive searches of PubMed and Embase databases up to April 2025. Data extraction and quality assessment were independently performed by two reviewers using the Newcastle–Ottawa Scale. Standardized mean differences (SMDs) and 95% confidence intervals were calculated using random-effects meta-analysis. Results: CTS patients exhibited significantly elevated serum levels of CCL2, CCL5, CXCL10, CXCL8, IL-4, VEGF, and TGF-β compared to controls. CCL4 was increased in the fixed-effect model but showed high heterogeneity; however, it was not statistically significant in the random-effects model and demonstrated extreme heterogeneity. No significant or consistent differences were observed for IL-1β, IL-6, IL-9, IL-10, TNF-α, or IFN-α. Conclusions: CTS is associated with a systemic pro-inflammatory and pro-fibrotic profile. CCL2, CCL5, IL-4, VEGF, and TGF-β may serve as promising biomarkers. Further large-scale, standardized studies are needed to validate these findings.